Chronic kidney disease
Three KDIGO guidelines: CKD evaluation and management (2024), anaemia in CKD (2026), which replaces the 2012 anaemia guideline, and the CKD-MBD update (2017).
Clinical pearls
- CKD = >3 months of abnormal structure or function; classify by Cause, GFR and Albuminuria.
- Pillars: RASi, SGLT2i (eGFR ≥20, continue below), statin, finerenone (T2D with albuminuria), GLP-1 RA.
- Anaemia: iron first; ESA target Hb <11.5 g/dL; HIF-PHIs are second line.
- CKD-MBD: treat trends; restrict calcium binders; dialysis PTH 2–9 × ULN.